HT-X1 MAX is an advanced holotomography (HT) imaging platform designed for comprehensive 3D analysis of organoids. It enables label-free visualization of entire organoids without staining, while maintaining optimal culture conditions for long-term time-lapse studies. Each acquisition provides valuable quantitative data, with support for a wide range of sample formats, from culture dishes to 96-well plates.
Gain detailed insights into organoid architecture, volume, and cell number before initiating screening experiments. Following treatment, continuously monitor individual organoids to assess response dynamics and investigate mechanisms of action (MoA). HT-X1 MAX seamlessly complements existing laboratory imaging workflows, expanding your capabilities for advanced organoid research and drug discovery.
1. Explore Beyond the Surface
Capture complete 3D organoid phenotypes at depths of up to 500 μm, revealing more than surface-level details.
2. Reveal Internal Cellular Architecture
Visualize cellular structures within living organoids without the need for staining or fixation.
Complete 3D Visualization of Organoids Without Staining
High-Depth 3D Imaging of Entire Organoids Holotomography enables detailed visualization of whole organoids up to 500 μm in depth, extending comprehensive structural analysis beyond smaller 3D models.
Label-Free Structural Imaging Combined with Fluorescence Holotomography reveals organoid architecture, nuclei, cellular layers, and luminal structures without staining. This preserves fluorescence channels for your selected molecular markers, enabling complementary structural and functional analyses.
Explore Organoid Architecture Down to the Cellular Level, Without Sectioning
Detailed Visualization of Cells and Subcellular Structures Examine individual cells throughout the epithelial layers and lumen, while identifying intracellular features such as lipid droplets and secretory granules for deeper insights into organoid organization.
Non-Invasive Imaging for Further Biological Analysis By revealing internal structures without physical sectioning or chemical fixation, holotomography preserves organoid integrity, allowing the same sample to be used in subsequent experiments and downstream assays.
Follow Organoid Development and Treatment Responses Over Time
Stable Culture Conditions for Extended Live Imaging An integrated stage-top incubator maintains controlled temperature, CO₂, and humidity, ensuring a suitable environment for continuous organoid imaging over hours or even days.
Longitudinal Analysis of Individual Organoids Unlike conventional endpoint assays that require separate samples at each time point, HT-X1 MAX enables repeated imaging of the same organoids throughout an experiment. This approach reduces sample consumption while providing detailed, organoid-specific growth and response profiles, revealing dynamic changes that population averages may overlook.
Comprehensive 3D Quantification of Organoid Structures and Cellular Features
AI-Driven Cell Counting Without Staining Holotomography reveals individual nuclei within intact organoids, enabling AI-powered detection and cell counting without fluorescent labeling or sample dissociation. Trained on HT datasets using fluorescence-based nuclear staining as a reference, the AI model provides quantitative cell-level insights while preserving organoid integrity.
Organoid-Specific Response Analysis Obtain detailed quantitative measurements for each individual organoid to investigate variations in treatment responses across different wells and drug concentrations. By moving beyond well-level averages, HT-X1 MAX enables more precise characterization of organoid heterogeneity and dose-dependent effects.
Applications
Drug Response
Measure IC50 from label-free nucleus counts, in line with the ATP assay.
HT-X1 MAX turns nucleus counts in live organoids into a dose–response curve. An AI model segments every nucleus directly from the 3D HT image, and in doxorubicin-treated colorectal cancer organoids the resulting IC50 matched the ATP assay run on the same plate. Unlike the lytic ATP assay, HT imaging leaves the organoids intact. Read every organoid first, then take the same plate on to other assays.
3.35 μMIC50, HT nucleus count3.46 μMIC50, ATP assay
Viability
Label-Free Viability Assessment of Living and Dead Organoids
Holotomography enables the assessment of cell viability by detecting differences in nuclear refractive index (RI) patterns between live and dead cells. This approach successfully distinguished untreated hepatic organoids from those exposed to H₂O₂, with results validated through AO/PI fluorescence staining. By eliminating the need for viability dyes, HT-X1 MAX allows repeated, non-invasive viability assessments throughout time-lapse experiments.
Cell Layer & Lumen
Reveal Structural Changes Through 3D Analysis of Cellular Layers and Lumens
HT-X1 MAX enables independent volumetric quantification of the cellular layer and lumen within each organoid, providing deeper insights into treatment-induced morphological changes. In doxorubicin-treated organoids, 3D imaging revealed a reduction in cellular layer volume accompanied by lumen expansion, despite unchanged overall organoid size. This detailed structural analysis uncovers subtle drug responses that conventional 2D imaging or size-based measurements may overlook.
Organoid Growth
Track Individual Organoid Growth with Quantitative 3D Time-Lapse Imaging
HT-X1 MAX enables continuous monitoring of living organoids, providing quantitative measurements of volume, dry mass, and nucleus count from each 3D acquisition. In a 25-hour observation, organoid volume increased 5.9-fold, while the number of nuclei rose only 1.6-fold. These findings highlight how volumetric growth does not necessarily reflect cellular proliferation, demonstrating the value of combining multiple quantitative parameters for a more accurate assessment of organoid development.
Lipid Droplets & Organelles
Label-Free Visualization of Lipid Droplets and Subcellular Structures in Live Organoids
HT-X1 MAX enables detailed imaging of intracellular structures within living organoids without fluorescent labeling. By combining high-resolution holotomography with refractive index (RI) contrast, the system reveals lipid droplets, condensed chromosomes, nucleoli, secretory granules, and vacuoles in a single 3D acquisition. In steatosis research, this non-invasive approach allows quantitative assessment of lipid droplet size and number in individual organoids, eliminating the need for lipid-specific staining.
Complex Organoids
Non-Invasive 3D Characterization of Mature and Complex Organoids
HT-X1 MAX enables comprehensive structural analysis of large, mature organoids without the need for physical sectioning. Its deep 3D imaging capabilities reveal intricate features such as crypt buds, elongated epithelial structures, and stromal networks within intestinal organoids in a single acquisition. By preserving organoid integrity, this approach allows researchers to evaluate tissue architecture and differentiation directly in living samples, providing valuable insights beyond conventional histological analysis.
Technical Features
Holotomography
Optics
NIR illumination, water-immersion objective
Field of view
500 × 500 μm
Imaging depth
Up to 500 μm
Resolution
Down to 122 nm lateral / 385 nm axial (theoretical)
HT-X1 MAX is an advanced holotomography (HT) imaging platform designed for comprehensive 3D analysis of organoids. It enables label-free visualization of entire organoids without staining, while maintaining optimal culture conditions for long-term time-lapse studies. Each acquisition provides valuable quantitative data, with support for a wide range of sample formats, from culture dishes to 96-well plates.
Gain detailed insights into organoid architecture, volume, and cell number before initiating screening experiments. Following treatment, continuously monitor individual organoids to assess response dynamics and investigate mechanisms of action (MoA). HT-X1 MAX seamlessly complements existing laboratory imaging workflows, expanding your capabilities for advanced organoid research and drug discovery.
1. Explore Beyond the Surface
Capture complete 3D organoid phenotypes at depths of up to 500 μm, revealing more than surface-level details.
2. Reveal Internal Cellular Architecture
Visualize cellular structures within living organoids without the need for staining or fixation.
3. Track Changes Over Time
Monitor individual organoids longitudinally to capture dynamic responses beyond conventional endpoint measurements.
4. Transform 3D Images into Quantitative Insights
Generate organoid-specific 3D measurements to support detailed dose–response analysis and drug screening.
Videos
News, events, promotions, webinars
High-Depth 3D Imaging of Entire Organoids
Holotomography enables detailed visualization of whole organoids up to 500 μm in depth, extending comprehensive structural analysis beyond smaller 3D models.
Label-Free Structural Imaging Combined with Fluorescence
Holotomography reveals organoid architecture, nuclei, cellular layers, and luminal structures without staining. This preserves fluorescence channels for your selected molecular markers, enabling complementary structural and functional analyses.
Detailed Visualization of Cells and Subcellular Structures
Examine individual cells throughout the epithelial layers and lumen, while identifying intracellular features such as lipid droplets and secretory granules for deeper insights into organoid organization.
Non-Invasive Imaging for Further Biological Analysis
By revealing internal structures without physical sectioning or chemical fixation, holotomography preserves organoid integrity, allowing the same sample to be used in subsequent experiments and downstream assays.
Stable Culture Conditions for Extended Live Imaging
An integrated stage-top incubator maintains controlled temperature, CO₂, and humidity, ensuring a suitable environment for continuous organoid imaging over hours or even days.
Longitudinal Analysis of Individual Organoids
Unlike conventional endpoint assays that require separate samples at each time point, HT-X1 MAX enables repeated imaging of the same organoids throughout an experiment. This approach reduces sample consumption while providing detailed, organoid-specific growth and response profiles, revealing dynamic changes that population averages may overlook.
AI-Driven Cell Counting Without Staining
Holotomography reveals individual nuclei within intact organoids, enabling AI-powered detection and cell counting without fluorescent labeling or sample dissociation. Trained on HT datasets using fluorescence-based nuclear staining as a reference, the AI model provides quantitative cell-level insights while preserving organoid integrity.
Organoid-Specific Response Analysis
Obtain detailed quantitative measurements for each individual organoid to investigate variations in treatment responses across different wells and drug concentrations. By moving beyond well-level averages, HT-X1 MAX enables more precise characterization of organoid heterogeneity and dose-dependent effects.
Drug Response
Measure IC50 from label-free nucleus counts, in line with the ATP assay.
HT-X1 MAX turns nucleus counts in live organoids into a dose–response curve. An AI model segments every nucleus directly from the 3D HT image, and in doxorubicin-treated colorectal cancer organoids the resulting IC50 matched the ATP assay run on the same plate. Unlike the lytic ATP assay, HT imaging leaves the organoids intact. Read every organoid first, then take the same plate on to other assays.
3.35 μMIC50, HT nucleus count3.46 μMIC50, ATP assay
Viability
Label-Free Viability Assessment of Living and Dead Organoids
Holotomography enables the assessment of cell viability by detecting differences in nuclear refractive index (RI) patterns between live and dead cells. This approach successfully distinguished untreated hepatic organoids from those exposed to H₂O₂, with results validated through AO/PI fluorescence staining. By eliminating the need for viability dyes, HT-X1 MAX allows repeated, non-invasive viability assessments throughout time-lapse experiments.
Cell Layer & Lumen
Reveal Structural Changes Through 3D Analysis of Cellular Layers and Lumens
HT-X1 MAX enables independent volumetric quantification of the cellular layer and lumen within each organoid, providing deeper insights into treatment-induced morphological changes. In doxorubicin-treated organoids, 3D imaging revealed a reduction in cellular layer volume accompanied by lumen expansion, despite unchanged overall organoid size. This detailed structural analysis uncovers subtle drug responses that conventional 2D imaging or size-based measurements may overlook.
Organoid Growth
Track Individual Organoid Growth with Quantitative 3D Time-Lapse Imaging
HT-X1 MAX enables continuous monitoring of living organoids, providing quantitative measurements of volume, dry mass, and nucleus count from each 3D acquisition. In a 25-hour observation, organoid volume increased 5.9-fold, while the number of nuclei rose only 1.6-fold. These findings highlight how volumetric growth does not necessarily reflect cellular proliferation, demonstrating the value of combining multiple quantitative parameters for a more accurate assessment of organoid development.
Lipid Droplets & Organelles
Label-Free Visualization of Lipid Droplets and Subcellular Structures in Live Organoids
HT-X1 MAX enables detailed imaging of intracellular structures within living organoids without fluorescent labeling. By combining high-resolution holotomography with refractive index (RI) contrast, the system reveals lipid droplets, condensed chromosomes, nucleoli, secretory granules, and vacuoles in a single 3D acquisition. In steatosis research, this non-invasive approach allows quantitative assessment of lipid droplet size and number in individual organoids, eliminating the need for lipid-specific staining.
Complex Organoids
Non-Invasive 3D Characterization of Mature and Complex Organoids
HT-X1 MAX enables comprehensive structural analysis of large, mature organoids without the need for physical sectioning. Its deep 3D imaging capabilities reveal intricate features such as crypt buds, elongated epithelial structures, and stromal networks within intestinal organoids in a single acquisition. By preserving organoid integrity, this approach allows researchers to evaluate tissue architecture and differentiation directly in living samples, providing valuable insights beyond conventional histological analysis.
Technical Features
Optics
NIR illumination, water-immersion objective
Field of view
500 × 500 μm
Imaging depth
Up to 500 μm
Resolution
Down to 122 nm lateral / 385 nm axial (theoretical)
Acquisition time
Approx. 15 s per 500 × 500 × 500 μm volume
Configuration
Spinning-disk confocal + widefield
Channels
4 channels, DAPI to far-red
Incubator
Integrated stage-top
Control
Temperature, CO₂, humidity; O₂ (optional)
Immersion water
Automatic supply
Pre-scan
96-well plate in approx. 10 s
Organoid finding
Automated pre-scan and ROI selection
Autofocus
Automated
96-well run
Approx. 30 min (one imaging point per well)
Labware
Dish, plate, slide; HT-Ready™ 96-well
AI quantification
Volume, sphericity, dry mass, nuclei, lumen
Reporting
Plate-level CSV, graphs, overlays
Dimensions / weight
1,399 × 833 × 812 mm (W × D × H) / approx. 300 kg